Clinical factors that reportedly impact the risk of reoperation after laparoscopic myomectomy due to leiomyoma recurrence include age, number and size of fibroids, size of uterus, type of surgery, parity after myomectomy and use of medical therapies such as GnRH analogs [11]. This evidence concerns the gene GNRH1 and leiomyoma.